Petvivo Holdings Inc. (PETV) 0.0055 $PETV
PetVivo Holdings, Inc. Announces Reverse Stock Split
ACCESSWIRE - Mon Sep 08, 2:53PM CDT
MINNEAPOLIS, MN / ACCESSWIRE / September 8, 2014 / PetVivo Holdings, Inc. (OTCPINK
ETVD) today announced completion of a 1-for-500 reverse stock split of outstanding shares of common stock in order to improve its capitalization structure and market appeal to the investor and financial community.
PetVivo Announces Commercial Launch Schedule
ACCESSWIRE - Tue Aug 19, 7:06AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / August 19th, 2014 / PetVivo Holdings, Inc. (OTCPINK ETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is pleased to announce the commercial launch schedule for their first three veterinary devices.
PetVivo Announces Expansion of Licensing & Planned Merger Partner's Patent Portfolio Through the Issuance of a Notice of Allowance by USPTO.
ACCESSWIRE - Wed Jul 23, 9:49AM CDT
MINNEAPOLIS, MN. / ACCESSWIRE / PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics announced today that Gel-Del Technologies, Inc., the licensing and planned merger partner of PetVivo, has received a notice of allowance for issuance of their seventh US Patent. PetVivo and Gel-Del recently announced the signing of a binding term sheet to effect a merger and security exchange agreement between the companies. Gel-Del's intellectual property assets include proprietary coverage for medical devices/therapeutics and the coacervated/compressed biomimetic matrix materials used to make these products, including composition of material, manufacturing processes and methods of use, for both animals and humans.
OTC Daily Trading Focus List: Axxess Pharma, Inc. Petvivo Holdings, Inc. Integrated Cannabis Solutions, Inc. BreedIT Corp, Affymax, Inc.
PR Newswire - Wed Jun 18, 10:45AM CDT
The overall trading in over the counter stocks remains light going into the summer with plenty of short term trades and volatility, which you would expect at this time of year. Traders like short term swings and we have focused on a group of stocks today that have not only been in the news this last week but have the potential to make moves higher after potentially being oversold
PetVivo Holdings Provides Update on Kush(TM) Study Results
Marketwire - Mon Jun 16, 6:04AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics, is pleased to provide an update on the Kush study results for treating animal osteoarthritis.
PetVivo Holdings, Inc. Announces Reverse Stock Split
ACCESSWIRE - Mon Sep 08, 2:53PM CDT
MINNEAPOLIS, MN / ACCESSWIRE / September 8, 2014 / PetVivo Holdings, Inc. (OTCPINK
ETVD) today announced completion of a 1-for-500 reverse stock split of outstanding shares of common stock in order to improve its capitalization structure and market appeal to the investor and financial community. PetVivo Announces Commercial Launch Schedule
ACCESSWIRE - Tue Aug 19, 7:06AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / August 19th, 2014 / PetVivo Holdings, Inc. (OTCPINK
ETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is pleased to announce the commercial launch schedule for their first three veterinary devices. PetVivo Announces Expansion of Licensing & Planned Merger Partner's Patent Portfolio Through the Issuance of a Notice of Allowance by USPTO.
ACCESSWIRE - Wed Jul 23, 9:49AM CDT
MINNEAPOLIS, MN. / ACCESSWIRE / PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics announced today that Gel-Del Technologies, Inc., the licensing and planned merger partner of PetVivo, has received a notice of allowance for issuance of their seventh US Patent. PetVivo and Gel-Del recently announced the signing of a binding term sheet to effect a merger and security exchange agreement between the companies. Gel-Del's intellectual property assets include proprietary coverage for medical devices/therapeutics and the coacervated/compressed biomimetic matrix materials used to make these products, including composition of material, manufacturing processes and methods of use, for both animals and humans.
OTC Daily Trading Focus List: Axxess Pharma, Inc. Petvivo Holdings, Inc. Integrated Cannabis Solutions, Inc. BreedIT Corp, Affymax, Inc.
PR Newswire - Wed Jun 18, 10:45AM CDT
The overall trading in over the counter stocks remains light going into the summer with plenty of short term trades and volatility, which you would expect at this time of year. Traders like short term swings and we have focused on a group of stocks today that have not only been in the news this last week but have the potential to make moves higher after potentially being oversold
PetVivo Holdings Provides Update on Kush(TM) Study Results
Marketwire - Mon Jun 16, 6:04AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics, is pleased to provide an update on the Kush study results for treating animal osteoarthritis.
